FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 361:101-102 July 2, 2009 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

Edited by Randall T. Hayden, Karen C. Carroll, Yi-Wei Tang, and Donna M. Wolk. 479 pp., illustrated. Washington, DC, ASM Press, 2009. $139.95. ISBN 978-1-55581-397-0.

Laboratory medicine has no more urgent role than in the diagnosis and management of infections in immunocompromised patients. For this vulnerable population, clinical algorithms are logically rooted in the need for timely identification, quantification, and genotyping of pathogens. The need to explain the roles, limitations, and evidence for the clinical utility of laboratory testing for these purposes is critical and is compounded by the rapid development of next-generation tests. This book is the first standard reference to focus specifically on issues that are unique to immunocompromised patients. It serves as a comprehensive overview of traditional and molecular methods of diagnosis . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.